Coloplast falls after Q4 margin miss

Coloplast A/S

05/11/2024 08:51

** Shares in Coloplast  COLOb.CO  fall 3.8% after the Danish
medical equipment maker posted Q4 margin below expectations,
citing negative impact from extraordinary costs and FX
    ** Q4 adj. EBIT was DKK 1.80 billion ($263.3 million), vs
DKK 1.90 billion expected in a company-provided consensus; Q4
margin 25.9% vs consensus of 27.5%
    ** Jefferies points to "weakish" EBIT margin, mainly due to
continued FX headwinds and extraordinary costs related to the
new U.S. distribution centre
    ** Coloplast sees 2024/25 organic growth of 8-9% and EBIT
margin before special items of about 28%
    ** Jefferies says the sales guidance is in line, but the
margin is "a tad below" consensus due to the lower jump-off
point
    ** "We think the new guide might be just enough for the
bulls. However, the bears will focus on the continued
disappointment at the margin level," J.P.Morgan says
    ** The shares are among top fallers on the pan-European
STOXX 600 index  .STOXX 

($1 = 6.8483 Danish crowns)

 (Reporting by Marta Frąckowiak)
 ((marta.frackowiak@thomsonreuters.com))